Amy Mcgrath Email & Phone Number

Paris, France, FR

Paris, France, FR

Tokyo, JP, JP

Global Commercial Lead for the first recombinant von Willebrand factor product. Responsible for the development and execution of the global launch strategy for a new product with multiple indications. Work internationally with affiliate countries to pull through global strategy into executional launch excellence.Significantly improved, quantified.

Engagements with clients from established international companies to start-up organizations. Developed and implemented commercial launch strategies and operational launch plans for late stage and post-launch products. Managed European launch of new reconstitution device for a leading hematology brand | Developed commercial Ad Board series, including first.

Responsible for global commercialization of the company's leading development project, a late stage drug for the treatment of Hemophilia B.Created product and corporate brand to position both within well-developed specialty market | Guided the development of a sophisticated, segmented, patient-based market model for sales planning and forecasting |.

Research Triangle Park, NC, US

Responsible for global budget of $2.5 million to provide commercial strategy and guidance at all stages of product development: from pre-clinical through to approved and marketed products. Led the development of Product Strategic Plans and participated on product development teams, routinely liaising with key personnel from process development, regulatory.

Leverkusen, North Rhine-Westphalia, DE

Managed comprehensive strategic marketing activities for plasma-derived FVIII. Collaborated with regional sales teams to develop and implement 5-year strategic plan.

Led 25 member team of field sales and support technicians in Ophthalmic division, overseeing sales, service and international distribution activities. Managed divisional finances and budgets, including full P&L responsibility. Reversed four-year decline in both sales and profitability by developing peripheral market to increase sales, achieving 20% growth.

Responsible for international marketing of $2M product line including international promotion, pricing strategy, distributor management and commercial guidance on new product development.

Responsible for sales of market leading diabetes care diagnostic equipment and reagents to medical professionals in southeast England. Consistent performance above plan.